Clinical Guideline / Consensus Statement Verifiedchecked 2026-09-07

European S2k guidelines on management of autoimmune blistering diseases in children and adolescents

Nanda A, Tedbirt B, Bodemer C et al.. Journal of the European Academy of Dermatology and Venereology : JEADV · 2026 · 40(7):1137-1161

European S2k guideline on the management of autoimmune blistering diseases.

Reference typeClinical Guidelines

Evidence levelClinical Guideline / Consensus Statement

JournalJournal of the European Academy of Dermatology and Venereology : JEADV

Year2026

Volume / Issue / Pages40 (7) 1137-1161

DOI10.1111/jdv.70308

PMID41678328

Publication typePractice Guideline

AuthorsNanda A, Tedbirt B, Bodemer C, Bolling MC, El Hachem M, Nikolić M

PubMed DOI Publisher / full text

Citation

Nanda A, Tedbirt B, Bodemer C et al.. European S2k guidelines on management of autoimmune blistering diseases in children and adolescents. Journal of the European Academy of Dermatology and Venereology : JEADV 2026. 40(7):1137-1161

Linked disease pages

Pemphigus Vulgaris

Mucous Membrane Pemphigoid

Related references

L3 · Systematic review

Clinical assessment to screen for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults

L2 · Guideline

Oral potentially malignant disorders: A consensus report from an international seminar on nomenclature and classification, convened by the WHO Collaborating Centre for Oral Cancer

L3 · Systematic review

THE PROPORTION OF ORAL LICHEN PLANUS CASES WITH MALIGNANT TRANSFORMATION MAY BE HIGHER, THAN REPORTED TO DATE